Financials

  • Market Capitalization 234.56 M
  • Employee 106
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.25
売上高対価格比率

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
3462
SRZN
Surrozen, Inc. - Common Stock
21.98 USD+0.46%-3.34%-5.22%+164.18%255.20 M USD
3479
RNAC
Cartesian Therapeutics, Inc. - Common Stock
8.48 USD-1.62%-14.69%-1.62%-7.42%249.16 M USD
3499
ACIU
AC Immune SA - Common Stock
2.39 USD-0.83%-3.24%+0.84%+16.59%243.16 M USD
3517
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.58 USD-0.28%-1.38%+1.42%-54.57%238.55 M USD